|
MED4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.965800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.148400E-02 |
| Normal-vs-Stage2 |
2.720400E-01 |
| Normal-vs-Stage3 |
6.448400E-01 |
| Normal-vs-Stage4 |
7.783400E-01 |
| Stage1-vs-Stage2 |
8.570400E-01 |
| Stage1-vs-Stage3 |
4.363600E-01 |
| Stage1-vs-Stage4 |
3.039200E-01 |
| Stage2-vs-Stage3 |
6.352400E-01 |
| Stage2-vs-Stage4 |
5.298400E-01 |
| Stage3-vs-Stage4 |
9.114600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.217830E-01 |
| Normal-vs-AfricanAmerican |
4.553700E-02 |
| Normal-vs-Asian |
5.911200E-01 |
| Caucasian-vs-AfricanAmerican |
3.234600E-01 |
| Caucasian-vs-Asian |
3.263000E-01 |
| AfricanAmerican-vs-Asian |
1.495160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.796850E-01 |
| Normal-vs-Female |
9.262200E-02 |
| Male-vs-Female |
6.035800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.802000E-01 |
| Normal-vs-Extreme_Weight |
1.950640E-01 |
| Normal-vs-Obese |
7.061500E-02 |
| Normal-vs-Extreme_Obese |
6.336000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.813600E-01 |
| Normal_Weight-vs-Obese |
2.911000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.529000E-01 |
| Extreme_Weight-vs-Obese |
5.103000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.879600E-01 |
| Obese-vs-Extreme_Obese |
4.572000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.637800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.684400E-03 |
| Normal-vs-Age(61-80Yrs) |
5.172400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.909000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.101180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.491000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.123600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.360900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.343800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.016600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.963200E-03 |
| Normal-VS-Type2 PRCC |
3.205200E-01 |
| Normal-VS-KIRP CIMP |
2.278200E-01 |
| Normal-VS-Unclassified PRCC |
1.264570E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.65520000004061E-07 |
| Type1 PRCC-VS-KIRP CIMP |
1.908000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.445600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.101200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.115600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.498100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.978600E-01 |
| Normal-vs-N1 |
2.732600E-01 |
| Normal-vs-N2 |
5.119000E-01 |
| N0-vs-N1 |
1.317400E-01 |
| N0-vs-N2 |
6.338600E-01 |
| N1-vs-N2 |
3.268600E-01 |
|
|
